SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058255
Filing Date
2023-11-02
Accepted
2023-11-02 16:23:01
Documents
94
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-20230930.htm   iXBRL 10-Q 4937155
2 EX-10.1 bbio-ex10_1.htm EX-10.1 44729
3 EX-31.1 bbio-ex31_1.htm EX-31.1 28267
4 EX-31.2 bbio-ex31_2.htm EX-31.2 28387
5 EX-32.1 bbio-ex32_1.htm EX-32.1 13372
6 EX-32.2 bbio-ex32_2.htm EX-32.2 13653
  Complete submission text file 0000950170-23-058255.txt   19002054

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbio-20230930_cal.xml EX-101.CAL 86046
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbio-20230930_lab.xml EX-101.LAB 896234
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbio-20230930.xsd EX-101.SCH 133736
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbio-20230930_pre.xml EX-101.PRE 687973
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbio-20230930_def.xml EX-101.DEF 532451
88 EXTRACTED XBRL INSTANCE DOCUMENT bbio-20230930_htm.xml XML 3938055
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 231372721
SIC: 2834 Pharmaceutical Preparations